Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
How might the integration of PET/CT with traditional imaging modalities alter the clinical decision-making process for suspected CIED infections without clear generator pocket involvement?
Related Questions
Do you use oral fosfomycin as a treatment option for uncomplicated cystitis due to ESBL producing E coli?
How do you manage recurrent C diff which occurs shortly after FMT when alternate etiologies of diarrhea have been excluded and patient is responding to C diff-directed therapies?
Do you treat with antibiotics active against methicillin-resistant staphylococci when a patient's culture grows non-lugdunensis, coagulase-negative staphylococci that tests susceptible to oxacillin by phenotypic testing, given the low constitutive PbP2A production of most CoNS?
Do you routinely recommend treatment for patients with chronic osteomyelitis of long bones based on radiographic findings alone in the absence of superficial infection or recommend bone biopsy to evaluate for therapy?
Do you routinely treat chronic sacral osteomyelitis when there is no plan for debridement or flap?
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
Under what circumstances would you treat a patient with an aortic graft infection for greater than 6 weeks of antibiotic therapy, whom has undergone total graft explanation and replacement?
How do you decide between ceftolozane/tazobactam and ceftazidime/avibactam for empiric treatment of an infection due to difficult-to-treat Pseudomonas aeruginosa while awaiting additional susceptibilities?
Is there any utility to trending Histoplasma serology titers to guide duration of therapy or treatment response for pulmonary histoplasmosis with negative urine antigen?
How have the results of the BALANCE trial, which demonstrated the noninferiority of 7 days of antibiotics compared to 14 days for non-S. aureus bloodstream infections, influenced your practice?
